99 related articles for article (PubMed ID: 15033837)
1. Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children.
Balfour-Lynn IM; Mohan U; Bush A; Rosenthal M
Arch Dis Child; 2004 Apr; 89(4):315-9. PubMed ID: 15033837
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
[TBL] [Abstract][Full Text] [Related]
3. Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Psuedomonas aeruginosa infection.
Bisgaard H; Pedersen SS; Nielsen KG; Skov M; Laursen EM; Kronborg G; Reimert CM; Høiby N; Koch C
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1190-6. PubMed ID: 9351621
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
Schmitt-Grohé S; Zielen S
Paediatr Drugs; 2005; 7(6):353-63. PubMed ID: 16356023
[TBL] [Abstract][Full Text] [Related]
5. Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis.
Miall LS; McGinley NT; Brownlee KG; Conway SP
Arch Dis Child; 2001 Feb; 84(2):160-2. PubMed ID: 11159295
[TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre.
Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D
Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902
[TBL] [Abstract][Full Text] [Related]
7. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
8. Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis.
Balfour-Lynn IM; Lees B; Hall P; Phillips G; Khan M; Flather M; Elborn JS;
Am J Respir Crit Care Med; 2006 Jun; 173(12):1356-62. PubMed ID: 16556691
[TBL] [Abstract][Full Text] [Related]
9. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
[TBL] [Abstract][Full Text] [Related]
10. Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.
Kabra SK; Pawaiya R; Lodha R; Kapil A; Kabra M; Vani AS; Agarwal G; Shastri SS
J Cyst Fibros; 2010 Jan; 9(1):17-23. PubMed ID: 19818694
[TBL] [Abstract][Full Text] [Related]
11. Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis.
Pantin CF; Stead RJ; Hodson ME; Batten JC
Thorax; 1986 Jan; 41(1):34-8. PubMed ID: 3518129
[TBL] [Abstract][Full Text] [Related]
12. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura.
Jayabose S; Mahmoud M; Levendoglu-Tugal O; Sandoval C; Ozkaynak F; Giamelli J; Visintainer P
J Pediatr Hematol Oncol; 1999; 21(6):514-7. PubMed ID: 10598663
[TBL] [Abstract][Full Text] [Related]
14. Oral steroids for cystic fibrosis.
Cheng K; Ashby D; Smyth R
Cochrane Database Syst Rev; 2000; (2):CD000407. PubMed ID: 10796717
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis.
Winnie GB; Cowan RG; Wade NA
J Pediatr; 1989 Feb; 114(2):309-14. PubMed ID: 2915293
[TBL] [Abstract][Full Text] [Related]
16. Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma.
Jakobsson T; Croner S; Kjellman NI; Pettersson A; Vassella C; Björkstén B
Allergy; 1994 Jul; 49(6):413-20. PubMed ID: 8074263
[TBL] [Abstract][Full Text] [Related]
17. Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis.
Ramsey KA; Ranganathan S; Park J; Skoric B; Adams AM; Simpson SJ; Robins-Browne RM; Franklin PJ; de Klerk NH; Sly PD; Stick SM; Hall GL;
Am J Respir Crit Care Med; 2014 Nov; 190(10):1111-6. PubMed ID: 25321321
[TBL] [Abstract][Full Text] [Related]
18. The Short-Term Effect of Breathing Tasks Via an Incentive Spirometer on Lung Function Compared With Autogenic Drainage in Subjects With Cystic Fibrosis.
Sokol G; Vilozni D; Hakimi R; Lavie M; Sarouk I; Bat-El Bar ; Dagan A; Ofek M; Efrati O
Respir Care; 2015 Dec; 60(12):1819-25. PubMed ID: 26374905
[TBL] [Abstract][Full Text] [Related]
19. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis.
Kozlowska WJ; Bush A; Wade A; Aurora P; Carr SB; Castle RA; Hoo AF; Lum S; Price J; Ranganathan S; Saunders C; Stanojevic S; Stroobant J; Wallis C; Stocks J;
Am J Respir Crit Care Med; 2008 Jul; 178(1):42-9. PubMed ID: 18403721
[TBL] [Abstract][Full Text] [Related]
20. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function.
Terliesner N; Vogel M; Steighardt A; Gausche R; Henn C; Hentschel J; Kapellen T; Klamt S; Gebhardt J; Kiess W; Prenzel F
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):815-821. PubMed ID: 28245190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
